<DOC>
	<DOCNO>NCT02108808</DOCNO>
	<brief_summary>Fractional flow reserve ( FFR ) establish invasive method assess physiological significance coronary artery stenosis . Adenosine , important endogenous regulator coronary blood flow stress ischemia , widely use achieve condition stable hyperemia require measurement FFR . Studies healthy volunteer patient acute coronary syndrome ( ACS ) post percutaneous coronary intervention ( PCI ) receive ticagrelor reveal differential coronary blood flow velocity response increase dos adenosine compare placebo prasugrel treat subject , respectively . It also demonstrate patient treated ticagrelor increase plasma adenosine level . Therefore , hypothesize degree hyperemia obtain adenosine infusion may great patient ticagrelor obtain patient take clopidogrel prasugrel . If prof true , would lead low FFR value possible important clinical implication ticagrelor receive patient need FFR measurement . This prospective , single center , randomize study parallel design . Consecutive ticagrelor naive patient refer coronary angiography angiographically moderate severe de novo stenosis ( &gt; 50 % &lt; 90 % diameter visual assessment ) least one major epicardial coronary artery amenable PCI candidate study . Patients informed consent randomize ( hour 0 ) receive immediately post FFR ( adenosine iintravenous infusion 140 Î¼g/Kg/min 3 minute period ) either ticagrelor 180mg load dose prasugrel 60mg/clopidogrel 600mg loading dose ( clinically indicate ) . FFR examination repeat 2 hour post load dose .</brief_summary>
	<brief_title>Effect Ticagrelor Fractional Flow Reserve</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Age 1880 year 2 . Patients subject clinically indicate coronary angiography least one 50 % 90 % stenosis 1 major epicardial vessel ( visual assessment ) amenable percutaneous coronary intervention . 3 . Ticagrelor naive patient 4 . Written inform consent 1 . History coronary artery bypass surgery 2 . Acute myocardial infarction within previous 5 day 3 . Known allergy adenosine , ticagrelor , prasugrel clopidogrel 4 . Prior intracranial hemorrhage 5 . Hemodialysis creatinine clearance &lt; 30ml/h 6 . Moderate/severe hepatic failure 7 . Active bleeding , increase risk bleed 8 . Left ventricular ejection fraction &lt; 40 % 9 . Primary myocardial valvular disease 10 . Contraindication adenosine 11 . Angiographically visible thrombus target lesion , extremely tortuous coronary artery , severely calcified lesion , leave main disease , anatomy suitable coronary artery bypass surgery 12 . Previous q wave myocardial infarction area target vessel 13 . Severe leave ventricular hypertrophy 14 . Severe valvular heart disease 15 . Heart failure define New York Heart Association class III IV 16.Hypotension ( blood pressure &lt; 90 mm Hg ) 17.Significant arrhythmia ( e.g . excessive premature ventricular contraction atrial fibrillation ) , tachycardia ( heart rate &gt; 120 beats/min ) , bradycardia ( &lt; 50 beats/min ) , increase risk bradycardia 18.Caffeine consumption cigarette smoking within previous 24 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>FFR</keyword>
	<keyword>adenosine</keyword>
	<keyword>Ticagrelor</keyword>
</DOC>